semaglutide zepbound Medicare GLP-1 Coverage for Weight Loss Starts July 2026: What You Need to Know FDA Approves Zepbound for Sleep
Description
The GLP-1 market is now worth more than $60 billion annually
Most patients self-administer once weekly into the abdomen, thigh or upper arm
They are also known for having some of the best low calorie food items, from any fast food restaurant
Even after shortages eased, some companies continued offering compounded alternatives, leading to ongoing disputes with pharmaceutical manufacturers
C Pharmacol
Weight loss surgery may seem intense and expensive, but it is often covered by insurers, and the out-of-pocket cost could be far less than years of GLP-1 therapy
